Read the latest positive news, breakthroughs, and inspiring stories about stomach cancer, curated daily by BrightWire.
Gilbert Rea survived leukemia and stage 4 stomach cancer—even after having his entire stomach removed. Now he's sharing hope as Mission Hope Cancer Center's 2026 Day of Hope Ambassador while still grilling tri-tip every game day.
Gilbert Rea conquered leukemia and stage 4 stomach cancer while keeping his legendary Sunday BBQ tradition alive. Now in remission, the California grandfather is sharing hope through his incredible comeback story.
Emergency physician Derek Cooney enrolled in a clinical trial at UT MD Anderson for stage 4 stomach cancer and experienced exceptional care that impressed even a medical professional. From hospitality to efficiency during a winter storm, three aspects of his treatment stood out.
Emergency physician Derek Cooney beat aggressive stage 4 stomach cancer through a groundbreaking clinical trial at MD Anderson. Just months after treatment, he completed his pain management fellowship and returned to caring for patients.
An emergency room physician from upstate New York traveled to UT MD Anderson for a groundbreaking clinical trial after a devastating stage 4 stomach cancer diagnosis. Today, Derek Cooney is cancer-free and back to helping patients.
Andrew Goodspeed survived stage 4 stomach cancer that had spread to 90% of his bones. Now he's pushing Congress to pass early detection guidelines that could save thousands of lives.
A new immunotherapy that helps the immune system fight stomach cancer is now available in England after a record-fast approval. More than 1,500 people each year could benefit from the treatment that significantly improves survival rates.
A new immunotherapy drug for aggressive stomach cancer just got the green light from the NHS, marking the first major treatment breakthrough in nearly ten years. About 1,500 people a year in the UK will now have access to a therapy that extends survival and reduces cancer recurrence.
Around 1,500 people with stomach cancer will gain access to a groundbreaking immunotherapy treatment that extends survival and reduces recurrence. It's the first major advance in stomach cancer care in nearly ten years.
Millions who take daily heartburn medication can breathe easier after a massive 26-year study across five countries found no link between long-term use and stomach cancer. The research finally puts to rest decades of anxiety for patients who depend on these drugs.